Jennifer R Donnan, Catherine A Grandy, Eugene Chibrikov, Carlo A Marra, Kris Aubrey-Bassler, Karissa Johnston, Michelle Swab, Jenna Hache, Daniel Curnew, Hai Nguyen, John-Michael Gamble. BMJ Open 2019
Times Cited: 77
Times Cited: 77
David Z I Cherney, Bruce A Perkins, Nima Soleymanlou, Maria Maione, Vesta Lai, Alana Lee, Nora M Fagan, Hans J Woerle, Odd Erik Johansen, Uli C Broedl, Maximilian von Eynatten. Circulation 2014
Times Cited: 783
Times Cited: 783
List of shared articles
Times cited
Sodium-glucose cotransporter 2 inhibitors benefit to kidney and cardiovascular outcomes for patients with type 2 diabetes mellitus and chronic kidney disease 3b-4: A systematic review and meta-analysis of randomized clinical trials.
Haiyan Cao, Youxia Liu, Zhixia Tian, Yuhang Lian, Junya Jia, Ming Liu, Dong Li. Diabetes Res Clin Pract 2021
Haiyan Cao, Youxia Liu, Zhixia Tian, Yuhang Lian, Junya Jia, Ming Liu, Dong Li. Diabetes Res Clin Pract 2021
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, Paola Fioretto, Kevin J Fowler, Hiddo J L Heerspink, Tom Manley, Darren K McGuire, Mark E Molitch, Amy K Mottl,[...]. Am J Kidney Dis 2021
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, Paola Fioretto, Kevin J Fowler, Hiddo J L Heerspink, Tom Manley, Darren K McGuire, Mark E Molitch, Amy K Mottl,[...]. Am J Kidney Dis 2021
SGLT2 inhibitor empagliflozin monotherapy alleviates renal oxidative stress in albino Wistar diabetic rats after myocardial infarction induction.
Ahmed S Ahmed, Marwa M Mona, Mona A Abdel-Kareem, Rasha A Elsisy. Biomed Pharmacother 2021
Ahmed S Ahmed, Marwa M Mona, Mona A Abdel-Kareem, Rasha A Elsisy. Biomed Pharmacother 2021
SGLT2 inhibitors: a narrative review of efficacy and safety.
Donald S Nelinson, Jose M Sosa, Robert J Chilton. J Osteopath Med 2021
Donald S Nelinson, Jose M Sosa, Robert J Chilton. J Osteopath Med 2021
Sodium-glucose cotransporter 2 inhibitors' mechanisms of action in heart failure.
Petra Grubić Rotkvić, Maja Cigrovski Berković, Nikola Bulj, Luka Rotkvić, Ivana Ćelap. World J Diabetes 2020
Petra Grubić Rotkvić, Maja Cigrovski Berković, Nikola Bulj, Luka Rotkvić, Ivana Ćelap. World J Diabetes 2020
Cardiorenal Syndrome in Type 2 Diabetes Mellitus - Rational Use of Sodium-glucose Cotransporter-2 Inhibitors.
Sanjay Kalra, Hasan Aydin, Manisha Sahay, Sujoy Ghosh, Sundeep Ruder, Mangesh Tiwaskar, Gary Kilov, Kamal Kishor, Tiny Nair, Vikas Makkar,[...]. Eur Endocrinol 2020
Sanjay Kalra, Hasan Aydin, Manisha Sahay, Sujoy Ghosh, Sundeep Ruder, Mangesh Tiwaskar, Gary Kilov, Kamal Kishor, Tiny Nair, Vikas Makkar,[...]. Eur Endocrinol 2020
Acute renal injury events in diabetic patients treated with SGLT2 inhibitors: A comprehensive review with a special reference to RAAS blockers.
André J Scheen, Pierre Delanaye. Diabetes Metab 2022
André J Scheen, Pierre Delanaye. Diabetes Metab 2022
Considerations and possibilities for sodium-glucose cotransporter 2 inhibitors in pediatric CKD.
Alexander J Kula. Pediatr Nephrol 2022
Alexander J Kula. Pediatr Nephrol 2022
Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease.
Tamara Y Milder, Sophie L Stocker, Richard O Day, Jerry R Greenfield. Drug Saf 2020
Tamara Y Milder, Sophie L Stocker, Richard O Day, Jerry R Greenfield. Drug Saf 2020
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, Paola Fioretto, Kevin J Fowler, Hiddo J L Heerspink, Tom Manley, Darren K McGuire, Mark E Molitch, Amy K Mottl,[...]. Diabetes 2021
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, Paola Fioretto, Kevin J Fowler, Hiddo J L Heerspink, Tom Manley, Darren K McGuire, Mark E Molitch, Amy K Mottl,[...]. Diabetes 2021
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease.
Clifford J Bailey, Caroline Day, Srikanth Bellary. Curr Diab Rep 2022
Clifford J Bailey, Caroline Day, Srikanth Bellary. Curr Diab Rep 2022
Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement.
Ajitesh Roy, Animesh Maiti, Anirban Sinha, Arjun Baidya, Asish Kumar Basu, Dasarathi Sarkar, Debmalya Sanyal, Dibakar Biswas, Indira Maisnam, Kaushik Pandit,[...]. Diabetes Ther 2020
Ajitesh Roy, Animesh Maiti, Anirban Sinha, Arjun Baidya, Asish Kumar Basu, Dasarathi Sarkar, Debmalya Sanyal, Dibakar Biswas, Indira Maisnam, Kaushik Pandit,[...]. Diabetes Ther 2020